Current Neurology and Neuroscience Reports

, Volume 11, Issue 1, pp 1–5

Failure of Vitamin Supplementation to Lower the Risk of Recurrent Stroke

Clinical Trial Report
  • 45 Downloads

References

  1. 1.
    Falk E, Zhou J, Moller J: Homocysteine and atherothrombosis. Lipids 2001, 36:S3–S11.CrossRefPubMedGoogle Scholar
  2. 2.
    Faraci FM, Lentz SR: Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35:345–347.CrossRefPubMedGoogle Scholar
  3. 3.
    Eikelboom JW, Hankey GJ, Anand SS, et al.: Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000, 31:1069–1075.PubMedGoogle Scholar
  4. 4.
    Tanne D, Sela BA: Neurological implications of hyperhomocysteinemia in patients with atherothrombotic disease. Ital Heart J 2003, 4:577–579.PubMedGoogle Scholar
  5. 5.
    Sánchez-Moreno C, Jimenez-Conde J, Martin A: Stroke: roles of B vitamin, homocysteine and antioxidants. Nutr Res Rev 2009, 22:49–67.CrossRefPubMedGoogle Scholar
  6. 6.
    McNulty H, Pentieva K, Hoey L, Ward M: Homocysteine, B-vitamins, and CVD. Proc Nutr Soc 2008, 67: 232–237.CrossRefPubMedGoogle Scholar
  7. 7.
    Solomons NW: Food fortification with folic acid: has the other shoe dropped? Nutr Rev 2010, 65:512–515.CrossRefGoogle Scholar
  8. 8.
    Spence JD: Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol 2007, 6:830–838.CrossRefPubMedGoogle Scholar
  9. 9.
    Wrone EM, Hornberger JM, Zehnder JL, et al.: Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 2004, 15:420–426.CrossRefPubMedGoogle Scholar
  10. 10.
    Zoungas S, McGrath BP, Branley P, et al.: Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol 2006, 47:1108–1116.CrossRefPubMedGoogle Scholar
  11. 11.
    House AA, Eliasziw M, Cattran DC, et al.: Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010, 303:1603–1609.CrossRefPubMedGoogle Scholar
  12. 12.
    Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, et al.: Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 2003, 41:2105–2113.CrossRefPubMedGoogle Scholar
  13. 13.
    Liem AH, van Boven AJ, Veeger NJ, et al.: Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol 2004, 93:175–179.CrossRefPubMedGoogle Scholar
  14. 14.
    Lonn E, Yusuf S, Arnold MJ, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567–1577.CrossRefPubMedGoogle Scholar
  15. 15.
    Bønaa KH, Njølstad I, Ueland PM, et al.: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578–1588.CrossRefPubMedGoogle Scholar
  16. 16.
    Ebbing M, Bleie O, Ueland PM, et al.: Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamin after coronary angiography: a randomized controlled trial. JAMA 2010, 300:795–804.CrossRefGoogle Scholar
  17. 17.
    Løland KH, Bleie O, Strand E, et al.: Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol 2010, 105:1577–1184.CrossRefPubMedGoogle Scholar
  18. 18.
    Ebbing M, Bønaa KH, Ueland PM, et al.: Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med 2010 Aug 4 [Epub ahead of print].Google Scholar
  19. 19.
    Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, et al.: Effects of homocysteine-lowering with folic acid plus vitamine B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010, 303:2486–2494.CrossRefPubMedGoogle Scholar
  20. 20.
    Albert C, Cook N, Gaziano JM, et al.: Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299:2027–2036.CrossRefPubMedGoogle Scholar
  21. 21.
    Potter K, Hankey GJ, Green DJ, et al.: The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc Disord 2008, 8:24.CrossRefPubMedGoogle Scholar
  22. 22.
    Toole JF, Malinow MR, Chambless LE, et al.: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291:565–575.CrossRefPubMedGoogle Scholar
  23. 23.
    Yang Q, Botto LD, Erickson JD, et al.: Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006, 113:1335–1343.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of NeurologyUniversity of IowaIowa CityUSA

Personalised recommendations